Bristol-Myers Squibb (BMY) Stock Price, Quote, News & History | Benzinga

Bristol-Myers Squibb Co (BMY) Stock Price, Quote, News & History

BMYNYSE

Trade with Public

Trade with Public

$64.72

0.570.89%

Last update: Aug 7, 7:18 PM

$64.59

0.440.69%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$64.24

Close

$64.72

Volume / Avg.

7.21M / 12.37M

Day Range

$63.79 - $64.73

52 Wk Range

42.52 - 68.10

Market Cap

$131.94B

P/E Ratio

14.13

Dividend Yield

3.93%

Exchange

NYSE

RSI

63

Short Interest

2.2%

Days to Cover

4.24

Recent Bristol-Myers Squibb Company News

Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment

FDA grants Replimune accelerated approval for TUDRIQEV in combination with nivolumab to treat advanced cutaneous melanoma.

Vandana Singh

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

AstraZeneca and Bristol Myers reportedly discuss a $400 billion merger as analyst assesses valuation, patent risks and regulatory hurdles.

Vandana Singh

Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today

Crude tumbles nearly 6% after Trump cancels a strike on Iran, lifting the S&P 500 1.3% and the Russell 2000 1.5% at midday Monday.

Piero Cingari

Yen Intervention And Falling Oil Help Stocks, But Selling In Korea Throws A Monkey Wrench

Falling Oil Please click here for an enlarged chart of United States Oil ETF (NYSE:USO). Note the following: Understanding the moves in oil are very important because they have been directly impacting

The Arora Report

Why Is Bristol-Myers Squibb Stock Surging Monday?

Bristol Myers Squibb and AstraZeneca in talks for a $400B mega-merger, potentially creating the world's 4th-largest drugmaker.

Kaustubh Bagalkote

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

12.78B

Investing Cash Flow (TTM)

-4.91B

Financing Cash Flow (TTM)

-11.71B

Free Cash Flow (TTM)

11.44B

Capital Expenditure (TTM)

-1.34B

Net Change in Cash (TTM)

-3.83B

Analyst Trends and Forecast

2

Feb

0

0

0

0

Mar

2

1

Apr

4

3

Jul

1

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$166.19B

PE Ratio (TTM)

14.13

PE Ratio (FWD)

9.29

PEG Ratio (TTM)

2.27

PS Ratio (TTM)

2.67

PB Ratio (TTM)

5.87

Earnings Yield % (TTM)

7.08%

Earnings Yield % (FWD)

10.76%

EV / EBITDA (TTM)

9.81

Price / EBITDA (TTM)

7.80

Price / Free Cash Flow (TTM)

11.46

Book Value / Share

$10.93

Company Debt

Total Debt

$43.12B

LT Debt

$42.09B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$12.02B

Total Cash

$8.72B

Debt to Equity

2.02

Issuance of Debt (TTM)

-$6.28B

Repayment of Debt (TTM)

-$12.02B

Key Statistics

Open

$64.24

Close

$64.72

Volume / Avg.

7.21M / 12.37M

Day Range

$63.79 - $64.73

52 Wk Range

42.52 - 68.10

Market Cap

$131.94B

P/E Ratio

14.13

Dividend Yield

3.93%

Exchange

NYSE

RSI

63

Short Interest

2.2%

Days to Cover

4.24

About

Sector

Health Care

Industry

Pharmaceuticals

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Bristol-Myers Squibb (BMY) stock?

A

You can purchase shares of Bristol-Myers Squibb (NYSE:BMY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bristol-Myers Squibb (BMY) competitors?

A

Other companies in Bristol-Myers Squibb’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Bristol-Myers Squibb (BMY) stock?

A

Bristol-Myers Squibb has a consensus price target of $62.19.

Q

What is the current price for Bristol-Myers Squibb (BMY)?

A

The stock price for Bristol-Myers Squibb (NYSE: BMY) is $64.5923 last updated August 7, 2026 at 7:18 PM EDT.

Q

Does Bristol-Myers Squibb (BMY) pay a dividend?

A

There are no upcoming dividends for Bristol-Myers Squibb.

Q

When is Bristol-Myers Squibb (NYSE:BMY) reporting earnings?

A

Bristol-Myers Squibb does not have any upcoming earnings scheduled.

Q

Is Bristol-Myers Squibb (BMY) going to split?

A

There is no upcoming split for Bristol-Myers Squibb.

Q

What sector and industry does Bristol-Myers Squibb (BMY) operate in?

A

Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.